Tenax Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 62   

Articles published

TENX 3.68 +0.02 (0.55%)
price chart
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics
Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market.
Related articles »  
Form 4 TENAX THERAPEUTICS, INC. For: May 01 Filed by: Jebsen Michael B
... SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549. STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of ...
Trader's Recap: Tenax Therapeutics, Inc. (NASDAQ:TENX), Gerdau S.A. (NYSE ...
Tenax Therapeutics, Inc. (NASDAQ:TENX) belongs to Healthcare sector. Its weekly performance is -2.13%. On last trading day company shares ended up $3.67.
Recap for Traders: NiSource Inc. (NYSE:NI), Merchants Bancshares Inc ...  Property Mentor
Tenax Therapeutics' (TENX) CEO John Kelley on Q2 2015 Results - Earnings ...
Greetings and welcome to the Tenax Therapeutics Second Quarter 2015 Business Review and Update. At this time, all participants are in a listen-only mode.
Related articles »  
Tenax Therapeutics Spotlights Academic Publication on Levosimendan in ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today highlighted a recently-published ...
Tenax Therapeutics Announces Analyst Day and Webcast on April 13, 2015
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the company will ...
Tenax Therapeutics Provides Clinical and Corporate Update
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today provided an update regarding ...
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, ...
Tenax Therapeutics' (TENX) CEO John Kelley on Q1 2015 Results - Earnings ...  Seeking Alpha (registration)
Related articles »  
Tenax Therapeutics Announces First Patients Enrolled in Phase 3 LEVO-CTS ...
Tenax Therapeutics, Inc. (formerly Oxygen Biotherapeutics) is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market.
Morrisville's Tenax studies experimental drug in cardiac surgery patients  Triangle Business Journal
Related articles »  
Tenax Therapeutics Issues Employment Inducement Award With Appointment of ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today confirmed Paula Bokesch, M.D.